NICU patients receiving more than twenty-five platelet transfusions.

Neonates who are high users of platelet transfusions appear to be at high risk for poor outcomes, especially respiratory failure. Future studies will examine whether group O neonates are more likely to develop refractoriness and whether certain neonates would have a higher magnitude of post-transfusion rise if they received ABO identical donor platelets.